Cook gains US nod for Zilver stent trial:
This article was originally published in Clinica
The US FDA has given Cook permission to start a 20-patient trial of its self-expanding nitinol stent for treating symptomatic vascular disease of the iliac arteries. The Zilver stent incorporates Cook's "Z-Stent" cell design for optimal strength while maintaining a strong, equally distributed radial force throughout the stented area of the artery, says the Bloomington, Indiana firm. It displays excellent kink resistance while conforming to tortuous anatomy and has multiple gold radiopaque markers at each end to enhance visibility under fluoroscopy.